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epithelial innate immunity during colonisation
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Control of Streptococcus pneumoniae colonisation at human mucosal surfaces is critical to
reducing the burden of pneumonia and invasive pneumococcal disease, interrupting trans-
mission, and achieving herd protection. Here, we use an experimental human pneumococcal
carriage model (EHPC) to show that S. pneumoniae colonisation is associated with epithelial
surface adherence, micro-colony formation and invasion, without overt disease. Interactions
between different strains and the epithelium shaped the host transcriptomic response
in vitro. Using epithelial modules from a human epithelial cell model that recapitulates our
in vivo ﬁndings, comprising of innate signalling and regulatory pathways, inﬂammatory
mediators, cellular metabolism and stress response genes, we ﬁnd that inﬂammation in the
EHPC model is most prominent around the time of bacterial clearance. Our results indicate
that, rather than being conﬁned to the epithelial surface and the overlying mucus layer, the
pneumococcus undergoes micro-invasion of the epithelium that enhances inﬂammatory and
innate immune responses associated with clearance.
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Colonisation of upper respiratory tract (URT) mucosa by arange of pathogenic bacteria is a necessary precursor toboth disease and onward transmission. Although Strep-
tococcus pneumoniae is a common coloniser of the human
nasopharynx, it is estimated to be responsible for >500,000 deaths
due to pneumonia, meningitis and sepsis in children under 5
years of age worldwide1.
In Europe and North America, there has been a dramatic effect
of pneumococcal conjugate vaccine (PCV) on vaccine serotype
(VT) invasive disease, carriage and transmission2. However, the
emergence of non-VT pneumococcal disease worldwide and the
more modest impact of PCV on colonisation in high transmission
settings, threaten this success3. Control of pneumococcal URT
colonisation in humans is not fully understood4, and so deﬁning
the mechanistic basis for host control of pneumococcal coloni-
sation at the mucosal surface is therefore crucial for the further
optimisation of therapeutic interventions which target carriage
and transmission. The process of transmission is not fully
understood, but mucosal inﬂammation, potentially enhanced by
co-infection with viruses such as Inﬂuenza A, has been proposed
to mediate bacterial shedding from the nasopharynx5.
Naturally acquired immunity to S. pneumoniae proteins are
primarily mediated by mucosal T cells and anti-protein anti-
bodies, controlled by Treg6–8. The role of anti-capsule poly-
saccharide antibodies in naturally acquired immune control
remains unresolved9. URT epithelium is central to this immu-
nity10, binding and transporting antibodies, sensing bacteria via a
range of surface and intracellular pathogen-associated molecular
patterns (PAMPs) receptors, and rapidly transducing signals to
recruit innate and inﬂammatory immune mechanisms11,12.
Murine models suggest that adherence of S. pneumoniae to the
mucosal epithelium may be followed by paracellular transmi-
gration and tight junction modulation13,14. In contrast, studies of
immortalised epithelial cell monolayers implicate endocytosis of
S. pneumoniae, mediated though pneumococcal protein
C–polymeric immunoglobulin receptor interactions15,16. The
relative importance of epithelial endocytosis and paracellular
migration in colonisation and invasion remains uncertain16, but
could inﬂuence epithelial sensing of this otherwise extracellular
pathogen14. For example this may include Nod1 signalling via
peptidoglycan17 and TLR4 signalling via pneumolysin, a pore-
forming toxin that induces inﬂammation and mediates both
clearance and transmission in an infant mouse model18–20.
Much of what we understand of the control of pneumococcal
colonisation is derived from epidemiological studies and mur-
ine carriage models. The experimental human pneumococcal
carriage (EHPC) model provides a well-controlled, repro-
ducible tool to characterise the cellular and molecular
mechanisms that underlie pneumococcal colonisation in
humans21. The model has revealed that pneumococcal carriage
results in neutrophil degranulation and monocyte recruitment
to the nasopharynx22, protecting against re-challenge with the
same strain for up to 1 year21,23.
Here, we explore the hypothesis that pneumococcal–epithelial
engagement dictates the inﬂammatory/innate immune response
and therefore the outcome of colonisation. We use the EHPC
model and human epithelial cell lines with different strains of S.
pneumoniae to probe these mechanisms and derive an epithelial
transcriptome module from the in vitro culture system to inter-
rogate the host response in the EHPC model. We show that
pneumococcal colonisation in humans is characterised by micro-
colony formation, junctional protein association and migration
across the epithelial barrier without disease, which we have
termed micro-invasion. This pattern of bacterial-host cell asso-
ciation shapes epithelial sensing of S. pneumoniae, which is
partially pneumolysin dependent. Together, our data suggest that
pneumococcal engagement with the epithelium in the early
phases of colonisation may occur without eliciting a marked host
response, but as colonisation becomes more established, epithelial
sensing of S. pneumoniae enhances innate immunity/inﬂamma-
tion which we propose promotes clearance.
Results
Adhesion, micro-colony formation and micro-invasion in
EHPC model. We have used an EHPC model21 to capture the
epithelial events central to pneumococcal colonisation, obtaining
human mucosal samples by curette biopsy. We deﬁned a carrier
as an individual colonised by 6B S. pneumoniae as detected by
culture of nasal wash at any day following inoculation. Clearance
was deﬁned as when S. pneumoniae colonisation became negative
by culture of nasal wash.
Colonisation was detected in 9/13 healthy volunteers by
culture, 12/13 by microscopy (using 6B capsule-speciﬁc antibody
labelling) and 9/11 by LytA PCR (Table 1). Carriage was detected
by culture/PCR at day 2, whereas maximum detection by
microscopy was evident at day 6. This is not explained by
colonisation density and therefore the sensitivity of culture/PCR.
This could be explained by greater association with the
epithelium (detected by all techniques) rather than the overlying
mucus (detected by culture/PCR but not microscopy) over time.
Clearance generally occurred between day 9 and day 27 (Table 1
and Fig. 1b).
Curette biopsy samples visualised by confocal microscopy
using wheat germ agglutinin (WGA) as a marker for surface
carbohydrates and junctional adhesion molecule-A (JAM-A) as a
marker of tight junctions, yielded intact sheets of epithelial cells
(Supplementary Fig. 1b) associated with polymorphonuclear
leucocytes, characterised morphologically (Fig. 1a and Supple-
mentary Fig. 1a). Amongst carriers, pneumococci were found on
the epithelial surface (Table 1; Fig. 1c, d, Supplementary Fig. 1b)
which over time (typically by 6 days), consisted of two or more
pneumococci at the same location on the epithelial surface, which
we have termed micro-colonies (Fig. 1e, Supplementary Fig. 1b).
There was evidence of what we have termed pneumococcal
“micro-invasion” of the epithelial monolayer consisting of either
internalisation of bacteria and/or transmigration across the
epithelial barrier (Fig. 1e, f). Pneumococci were also observed
in phagocytic cells (Supplementary Fig. 1a). Colonisation was
frequently characterised by co-association between S. pneumoniae
and JAM-A (Fig. 1f). This intimate association between
inoculated pneumococci and the mucosa during asymptomatic
pneumococcal carriage in humans is suggestive of an active
engagement process which may inﬂuence the outcome of
colonisation.
Further visualization of this bacteria–host interaction by
transmission electron microscopy has proven problematic
in vivo, but we have been able to demonstrate the integrity of
the nasal epithelial curette biopsy samples (Supplementary
Fig. 1b). We provide evidence of diplococci on the epithelial cell
surface and chains or micro-colonies of diplococci that may have
been dislodged from the epithelial surface (Supplementary
Fig. 1b).
Epithelial surface marker expression in vivo is unaltered dur-
ing colonisation of S. pneumoniae. To determine whether
pneumococcal colonisation leads to epithelial activation, we
analysed nasal curette biopsy cells for surface expression of
molecules expressed in airway epithelium which have pre-
viously been shown to be upregulated in response to common
bacterial stimuli and are involved in immune cell recruitment.
These were EpCAM (for epithelial cell identiﬁcation),
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IL-22Ra1, HLADR, CD40, CD54 and CD107a (Supplementary
Fig. 2a-d). We did not detect a signiﬁcant change in the relative
expression of IL-22Ra1 (protects the epithelial barrier, pro-
motes anti-microbial product secretion during infection,
modulating pneumococcal carriage and clearance24), HLADR
(mediates T cell-antigen recognition and is a marker of epi-
thelial activation25), CD40 (co-stimulatory protein which binds
CD15426 (Supplementary Fig. 2e-g)), or CD54 (a leucocyte
adhesion molecule which is also upregulated by CD4026,27,
initiating neutrophil migration and recruitment28, Fig. 2a).
However, although numbers of epithelial cells expressing
CD107a did not change over time (Fig. 2b, left), we observed an
increase in CD107ahigh expression at day 2 post inoculation in
carriage positive volunteers vs. carriage negative volunteers
(Fig. 2b, right). CD107a in the epithelium forms the membrane
glycoprotein of late endosomes and phagolysosomes16 and has
previously been implicated in pneumococcal endocytosis16.
These data highlight the ability of the pneumococcus to colo-
nise the nasopharynx without marked inﬂammation and
potentially implicate CD107a in the process.
Adhesion, micro-colony formation and micro-invasion
in vitro. To further understand epithelial responses to S. pneu-
moniae observed in the EHPC model, we undertook infection
experiments with Detroit 562 epithelial cells. We compared the
6B response with two other representative clinical isolates: a 23F
strain, TIGR4 (the original sequenced strain29) and a TIGR4
pneumolysin deletion mutant strain (dPly).
TIGR4 association with Detroit 562 cells was over 100-fold
higher for adhesion and over 70-fold higher for invasion after 3 h
infection, compared with 6B or 23F strains (Fig. 3a, b). Using
capsule-speciﬁc antibody stain for confocal and electron micro-
scopy, pneumococcal adhesion to the epithelial surface at 3 h was
found to be associated with micro-colony formation, pneumo-
coccal chain formation and internalisation of this conventionally
extracellular pathogen14 (Fig. 3d–f, j, k, Supplementary Fig. 3a).
Internalisation was associated with the formation of epithelial
membrane folds (Fig. 3k left). Intracellular pneumococci were
contained within intracellular vesicles suggestive of endocytosis,
which was most marked with the TIGR4 and dPLY-TIGR4
strains (Fig. 3b, g, k)16. Intracellular pneumococci were seen
Table 1 S. pneumoniae association with the nasal epithelium in the EHPC model detected by culture, confocal microscopy and
LytA PCR
Sample day Pneumococcal association
ID Pneumococcal density Pre D2 D6 D9 D27 Surface Intracellular Lateral
1 Culture (CFU/ml) 0 373 520 10 2
Microscopy (counts) 0 + + 0 + + 0 0
LytA PCR NEG POS POS n/a POS
2 Culture (CFU/ml) 0 0 0 0 0
Microscopy (counts) + + 0 0 0 ++ + 0
LytA PCR NEG NEG NEG n/a NEG
3 Culture (CFU/ml) 0 0 0 0 0
Microscopy (counts) 0 + 0 0 0 + 0 0
LytA PCR NEG POS NEG n/a NEG
4 Culture (CFU/ml) 0 3 9 0 0
Microscopy (counts) 0 0 0 + 0 + 0 0
LytA PCR NEG POS POS n/a NEG
5 Culture (CFU/ml) 0 7 × 103 223 22 0
Microscopy (counts) 0 + + + 0 + + 0
LytA PCR n/a n/a n/a n/a n/a
6 Culture (CFU/ml) 0 1.9 × 104 5.7 × 103 3.7 × 104 11
Microscopy (counts) 0 ++ ++++ ++ 0 +++ ++ +
LytA PCR NEG POS POS n/a POS
7 Culture (CFU/ml) 0 822 1.1 × 103 160 0
Microscopy (counts) 0 + +++ ++ 0 ++ + +
LytA PCR NEG POS POS n/a NEG
8 Culture (CFU/ml) 0 0 0 0 0
Microscopy (counts) 0 0 0 0 0 0 0 0
LytA PCR n/a n/a n/a n/a n/a
9 Culture (CFU/ml) 0 221 695 4 <1
Microscopy (counts) n/a + +++ + n/a +++ + +
LytA PCR NEG POS POS n/a NEG
10 Culture (CFU/ml) 0 1 × 103 0 0 0
Microscopy (counts) n/a 0 + 0 n/a + 0 0
LytA PCR NEG POS POS n/a POS
11 Culture (CFU/ml) 0 1.8 × 106 1.8 × 106 1.9 × 104 <1
Microscopy (counts) n/a ++++ ++++ + n/a +++ + +
LytA PCR NEG POS POS n/a NEG
12 Culture (CFU/ml) 0 0 0 0 0
Microscopy (counts) n/a ++ 0 0 n/a ++ + +
LytA PCR NEG NEG NEG n/a NEG
13 Culture (CFU/ml) 0 23 2 0 0
Microscopy (counts) n/a + 0 0 n/a + 0 0
LytA PCR POS POS POS n/a POS
Nasal washes and nasal curette biopsies were collected from carriage positive and carriage negative volunteers over time. Standard methods for measuring bacterial density by culture (CFU) and LytA
PCR were compared against counts visualised by confocal microscopy for pneumococcal association with nasal cells over time. The data were derived from 13 volunteers. +(1–10 pneumococci); ++
(11–50 pneumococci); +++(51–100 pneumococci); ++++ (>100 pneumococci); n/a= reading not taken
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Fig. 1 Pneumococcal colonisation in the EHPC model is associated with adhesion, micro-colony formation and micro-invasion. a Representative ﬁelds from
the EHPC model nasal curette biopsies show intact epithelium can be obtained from the samples (as visualised by XY planes) and they retain their size and
shape (as visualised by XZ planes). Cells were stained with wheat germ agglutinin (WGA) or junctional adhesion molecule-A (JAM-A, red) and nuclei
(blue). b The pattern of pneumococcal density detected by culture and microscopy. The total bacterial sum across volunteers is shown. c The proportion of
bacteria located on the cell surface, intracellularly, or paracellularly visualised by confocal microscopy, quantiﬁed from eight volunteers collected over time
from microscopy counts. b, c Error bars represent s.e.m. d Cells were stained for surface carbohydrates using WGA (red), and the bacteria were marked
with speciﬁc serotype antiserum (green). XY images of 1 µm slices through a layer of cells from top (stack 1) to bottom (stack 4), with bacteria associated.
e Examples of cells collected on day 6 post inoculation stained with WGA (red) showing; (MC) micro-colony formation on the surface of the epithelium,
(IN) bacterial internalization, (TM) transmigration through epithelial uptake internally or between cells. f Co-association between S. pneumoniae (green)
and JAM-A (red). Nuclei (blue). Bacterial uptake appeared co-associated with JAM-A (yellow). All scale bars represent 10 μm
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within vacuoles (Fig. 3k middle), coated with JAM-A (a tight
junction protein that regulates barrier function and cell polarity,
Fig. 3g, Supplementary Fig. 3a) and associated with the adherens
junction protein β catenin (that is involved in epithelial adhesion,
Fig. 3g (top right) and Fig. 3h), but not Claudin-4 (a tight
junction protein that regulates paracellular permeability, Supple-
mentary Fig. 3a). Pneumococci were located laterally, transiting
between cell junctions (Fig. 3h, k right), at the level of the nuclei
and, below the basal membrane (Fig. 3i). Transmigration across
the epithelium (endocytosis or paracellular movement), as
measured by the culture of pneumococci from the basal chamber
of transwell inserts, was most marked with 23F (Fig. 3c, ﬁvefold
higher compared with TIGR4, after 3 h infection). A similar
pattern of epithelial interaction was also seen at 1 h suggesting
these observations are not simply explained by differential
growth.
Epithelial infection with the dPly-TIGR4 mutant showed a
signiﬁcant increase in adherence (Fig. 3a, tenfold higher after 3 h
infection), internalisation (Fig. 3b, threefold higher after 3 h
infection, Fig. 3k), but no signiﬁcant differences in transmigration
(Fig. 3c) compared with the wild-type strain, implicating
pneumolysin in the modulation of bacterial interactions with
the epithelium.
Similar patterns of adherence and invasion were observed
in infection experiments with human Calu3 and A549 epithelial
cells demonstrating that these ﬁndings are cell-line independent
(Supplementary Fig. 4). Furthermore, primary epithelial cells
differentiated on an air-liquid interface for 30 days and co-
cultured with either 6B or 23FS. pneumoniae also revealed
pneumococcal micro-colony formation, micro-invasion and
epithelial junctional protein association (Supplementary
Fig. 1c).
Together these data show the strain dependency of
pneumococcal–epithelial interactions in vitro which mirror the
epithelial micro-invasion (both internalisation and/or transmi-
gration of pneumococci) seen in vivo.
Endocytosis-related micro-invasion and transmigration. To
conﬁrm that the pneumococcal endocytosis leads to transmigra-
tion across the epithelium, endocytosis was inhibited with
dynasore and nystatin16. After 1 h of infection, cellular uptake of
23F was inhibited by 82% (Fig. 4a) and transmigration across the
cell monolayer by 85% (Fig. 4b). In agreement with previous
studies using A549 and Calu3 cells30, we found that viable
pneumococci in Detroit 562 cells decreased over time (Supple-
mentary Fig. 5a). Using gentamicin treatment to eliminate the
original extracellular inoculum, we observed S. pneumoniae in the
apical and basal media (Supplementary Fig. 5b), suggesting egress
from the epithelium.
Micro-invasion does not compromise epithelial barrier func-
tion. S. pneumoniae has been shown to affect the integrity of
epithelial barriers and tight junction function in murine
models13,31. Having demonstrated pneumococcal micro-invasion
without marked epithelial morphological disruption both by
confocal and electron microscopy, we explored possible effects on
epithelial barrier function by measuring trans-epithelial electrical
resistance (TEER) and permeability to 4 kDa FITC-dextran in
Detroit 562 cells. TEER was not adversely affected by pneumo-
coccal co-culture (Fig. 4c) and permeability was maintained with
all the pneumococcal strains at 3 h post-infection (Fig. 4d).
Although co-localisation of pneumococci was seen with host
proteins, we did not detect marked epithelial membrane
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Fig. 2 Epithelial surface marker expression in vivo is unaltered during colonisation of S. pneumonia. Epithelial cells from nasal curette biopsies were analysed
by ﬂow cytometry for a CD54 and b CD107a. Results were expressed as median ﬂuorescence intensity (left) and high cell surface expression (≥95% of the
baseline expression, right) representing at least two volunteers per time point who were carriage negative (black) and carriage positive (grey).
Comparisons between carriage negative and carriage positive, on each day of sampling, was analysed by one-way ANOVA (a—parametric, b—non-
parametric). P= 0.84 CD54 MFI; P= 0.98 CD54 %; P= 0.09 CD107a MFI; P= 0.10 CD107a %. Boxplots represent the median (centre line) and
interquartile range (box), minimums and maximums (whiskers)
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carbohydrate or protein re-distribution (WGA, Claudin-4 JAM-
A, β catenin, Supplementary Fig. 3a). Similar observations were
made with A549 cells and Calu3 cells (Supplementary Fig. 4).
These data suggest that pneumococcal micro-invasion was not
dependent on loss of epithelial cell barrier function during early
interactions.
S. pneumoniae upregulation of epithelial CD54 and CD107a
in vitro. In a similar manner to primary cells collected from nasal
curettes, we assessed Detroit 562 cell surface marker expression in
response to S. pneumoniae (Supplementary Fig. 6). There were no
signiﬁcant changes in IL-22Ra1, HLADR or CD40 expression in
response to 6B, 23F, TIGR4 and dPly-TIGR4 strains (Supple-
mentary Fig. 6d–f). However, CD54high expression was sig-
niﬁcantly greater in response to the TIGR4 and dPly-TIGR4
strains, compared with non-infected cells (Fig. 5a). Epithelial
CD107a was upregulated in response to the 6B, 23F and
TIGR4 strains (Fig. 5b), but this was not seen with dPly-TIGR4.
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These data implicate pneumolysin in the induction of CD107a
but not CD54 epithelial surface expression and support the
possibility that CD107a is involved in pneumococcal–epithelial
micro-invasion events seen in vivo.
S. pneumoniae induces epithelial secretion of IL-6, IL-8 and
CD54 in vitro. To assess the inﬂammatory consequences of
pneumococcal–epithelial infections in vitro, we measured a
cytokine panel in Detroit 562 cell supernatants following S.
pneumoniae incubation (Fig. 5c). We detected a signiﬁcant
increase in IL-6 and IL-8, which were strain dependent and
partially pneumolysin dependent. In line with surface marker
observations, only TIGR4 signiﬁcantly upregulated the secretion
of soluble CD54, which was dependent on pneumolysin (Fig. 5c).
These data highlight the less inﬂammatory nature of the 6B strain
compared with the more invasive strain, TIGR4, and the
importance of pneumolysin in the epithelial response. Pneumo-
coccal wild-type strain differences were not explained by differ-
ences in pneumolysin activity, as determined by haemolysis
(Supplementary Fig. 7).
Epithelial innate transcriptomic responses to infection in vitro.
To explore the hypothesis that the pattern of epithelial adhesion
and micro-invasion results in differential epithelial responses, we
performed RNAseq of Detroit 562 cells infected with our panel of
S. pneumoniae strains. In comparison with non-infected epithelial
cell cultures, infection with TIGR4 upregulated expression of
1127 genes (517 unique genes), 23F upregulated 650 genes (69
Fig. 3 Pneumococcal infection in vitro is associated with adhesion, micro-colony formation and micro-invasion. Pneumococcal a association and b
internalisation: Detroit 562 cell monolayers were stimulated with pneumococci for 1 or 3 h and the quantity of associated bacteria was determined by
culture (CFU); n= 6. ****P= < 0.0001, ***P= 0.0001. a 1 h (dashed lines, ANOVA); 3 h (solid lines, Kruskall–Wallis); b (Kruskall–Wallis). c Pneumococcal
transmigration: Cells on transwell inserts were stimulated with pneumococci for 3 h and bacterial density in the basal chamber was determined (**P=
0.0092, Kruskall–Wallis). N= 5. a–c Error bars represent s.e.m. d Representative pneumococcal-density (green) images of cells (blue nuclei). Scale bar=
20 µm. n= 5. e–h Representative images of pneumococcal localization (green) from cells (red, JAM-A), illustrating: e differences in adherence by 6B and
TIGR4; f micro-colony and chain formation (green) dPly-TIGR4 (green) and WGA (red); g internalised bacteria (top 6B; bottom TIGR4) co-localised with
JAM-A with associated intracellular vesicle-like bodies (yellow), or co-associated with β catenin, top right; h lateral localisation of pneumococci (XY
images, TIGR4 (green) and JAM-A (red)) with possible paracellular movement of 6B (green) co-associated with β catenin (red) (XZ images); i basal
localisation of bacteria (23F, green) at the level of nuclei (blue) and insert pores N= 5 with replicates. Scale bar= 10 µm. j Scanning EM images of Detroit
562 cells infected with S. pneumoniae which appear as diplococci. Left—pneumococcal chain formation (strain 23F, arrow, scale bar= 4 µm); middle and
right—micro-colony formation by strains 6B and TIGR4 on the epithelial surface (scale bar= 10 µm). kMicro-invasion of dPLY-TIGR4 shown by EM: left—
scanning EM showing epithelial membrane folding (arrows) and pneumococci below the cell membrane surface (* scale bar= 2 µm); middle—
internalisation of TIGR4 pneumococci encased within a vacuole (arrow, scale bar= 2 µm); and right—transmission EM showing transmigration of dPLY-
TIGR4 pneumococci between epithelial cells (arrow, scale bar= 0.5 µm)
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Fig. 4 Pneumococcal micro-invasion is endocytosis-dependent and occurs without loss of barrier function. a, b Detroit 562 cells were treated with
dynasore and nystatin for 30min prior to and during incubation with 23F, for 1 h. a Intracellular bacteria were quantiﬁed using a gentamicin protection
assay and CFUs counted (****P= < 0.0001, Mann–Whitney). b Transmigrated bacteria after 1 h were counted by CFUs (*P= 0.013 Mann–Whitney). N=
4. c, d Cells were co-infected with pneumococci for 3 h on transwell inserts and barrier function was measured. c Trans-epithelial electrical resistance
(TEER) was compared before and after exposure to pneumococci. N= 9. Calcium withdrawal was used as a positive control (***P= 0.0013, unpaired T-
test, n= 3). d Permeability was assessed by leak to 4 kDa FITC-dextran, collected from basal chamber. N= 4. ****P= < 0.0001 comparing non-infected
against pneumococci (Kruskall–Wallis). Blank inserts were used as a positive control (Mann–Whitney). Error bars represent s.e.m.
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unique genes), and 6B upregulated 153 genes (10 unique genes)
(Fig. 6a). The pneumolysin deﬁcient isogenic mutant of TIGR4
upregulated 220 genes (14 unique genes). Compared with non-
infected cells, 1193 genes were upregulated by S. pneumoniae
infection overall and 93 were core to all strains tested (differen-
tially upregulated genes in Supplementary Data 1 and Reactome
pathways in Supplementary Data 2).
To elucidate the pathways that drive the transcriptional
responses to each strain, we also undertook transcription factor
binding site enrichment analysis (Fig. 6b, transcription factor
binding site enrichment analysis in Supplementary Data 3). The
responses to 6B and pneumolysin deﬁcient strains were
principally enriched in binding sites for the NFkB/Rel family of
transcription factors, indicating that an NFkB activation pathway
was the dominant driver for responses to these strains. In
contrast, cellular responses to TIGR4 and 23F strains revealed
enriched binding sites for more diverse transcription factors,
suggesting broader molecular pathways by which these strains
may inﬂuence cellular function. This analysis revealed particular
enrichment of binding sites for beta-beta-alpha zinc ﬁnger
superfamily of transcription factors, including KLF4, suggesting
that these strains upregulate mitogen activated protein kinase
pathways upstream of these transcription factors32.
The sets of genes upregulated by each strain individually were
subjected to core and interactome and pathway-enrichment
analysis for functional annotation of the cellular response at
systems level (Fig. 6c). From 20 clusters of pathways, signiﬁcant
enrichment of innate immune system responses was evident in all
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Fig. 5 Epithelial innate activation following pneumococcal infection in vitro. a, b Detroit 562 cells were stimulated with S. pneumoniae for 6 h and the median
ﬂuorescence intensity and high-expressing cells for (a) CD54 and (b) CD107a were analysed by ﬂow cytometry. n= 3 independent experiments (****P <
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strains and included speciﬁc enrichment in Toll receptor
cascades, peptide ligand-binding receptors, NFkB and MAP
kinase activation, Interferon signalling and cytokine and
chemokine signalling (Fig. 6c, d, Supplementary Fig. 8). In
general, each pneumococcal strain induced a distinct transcrip-
tomic proﬁle, with TIGR4 and 23F strains inducing a broader
number of biological pathways than the 6B strain (Fig. 6c). Fewer
transcriptional responses at the level of functional pathways in
response to dPly-TIGR4 is consistent with a role for pneumolysin
in innate immune recognition of S. pneumoniae33. Fewer
transcriptional responses to 6B is consistent with our observa-
tions that this strain exhibits the lowest level of cellular
association and transmigration.
Epithelial transcriptomic responses to 6B are detectable
in vivo. Next, we sought to test whether these epithelial tran-
scriptomic responses to S. pneumoniae were also evident in the
6B EHPC model. We compared nasal transcriptomes sampled at
2 or 9 days after inoculation with pre-inoculation samples. These
revealed enrichment of 162 transcripts among individuals who
became colonised (differential gene expression in Supplementary
Data 4). These genes included Claudin 5 and Claudin 17,
Defensin β 103A/B, Cadherin 16, Desmocollin 1 and Gap junc-
tion protein α1, which suggests cytoskeletal re-organisation
2 days post inoculation in carriage positive individuals. By day
9 post inoculation, molecules such as CCR3, matrix metallopro-
teinase 12 and MHC II molecules were enriched, suggesting
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Fig. 6 Transcriptomic responses to S. pneumoniae in vitro are inﬂuenced by adhesion and micro-invasion. a The total number of Detroit 562 epithelial genes
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activation of the nasal mucosa34. However, these genes were not
signiﬁcantly enriched for any immune response pathway anno-
tation perhaps because of the statistical stringency necessary for
genome-wide multiple testing and were not epithelial-speciﬁc.
Gene expression modules can successfully detect speciﬁc
transcriptional programs in bulk tissue35. Therefore, as an
alternative approach, we sought to target speciﬁc epithelial
responses in vivo using the in vitro interactome. A direct
comparison of transcripts for 6B revealed FOSL-1, an AP-1
transcription factor subunit, to be enriched with carriage, which
has previously been reported to become activated following
pneumococcal challenge in BEAS-2B and HEK293 cells36. To
expand the sensitivity of the approach, we evaluated the
expression of two transcriptional modules in the nasal samples
(Fig. 7). A ‘core’ module comprised of 16 interacting genes
(Fig. 7b) that were upregulated in the Detroit epithelium by all
the pneumococcal strains from Fig. 7a, and a second ‘integrated’
module that comprised of 200 interacting genes (Fig. 7c), which
were upregulated in the Detroit epithelium by at least one of the
pneumococcal strains from Fig. 7a. Among carriage negative
individuals, we found no increase in expression in either gene
expression modules (Fig. 7b, c). In contrast among the individuals
who became colonised, the increased expression of both modules
(signiﬁcantly increased within the integrated module, Fig. 7b, c),
suggests that the prominence of responses at day 9 may reﬂect
time-dependent proliferation of the 6B bacterial inoculum,
epithelial engagement and the subsequent epithelial activation.
These responses coincide around the time of bacterial clearance.
Discussion
It is widely accepted that colonisation of the URT mucosa by
many potentially pathogenic bacterial species, involves transient
association with the overlying mucus layer but that adherence to
the epithelial surface avoids mucus entrapment and muco-ciliary
clearance14,37. While evading immunity, bacterial replication then
occurs prior to onward transmission to a new host. Even for S.
pneumoniae, the mechanisms underlying this transition from
acquisition to established colonisation, and then transmission
and/or disease, are not well understood. By combining an EHPC
model and in vitro human cell culture systems, we show that
pneumococcal colonisation leads to epithelial adherence, micro-
colony formation and migration across the epithelial barrier
without disease, which we have termed micro-invasion. The
ﬁnding of co-association with junctional proteins provides a
possible mechanism for micro-invasion. Clearance of the pneu-
mococcus from the mucosa in vivo occurs in the context of
micro-invasion. Indeed, epithelial micro-invasion and not bac-
terial load per se, appears to dictate unique transcription factor
binding site signatures, downstream cytokine, chemokine and
metabolic pathway enrichment (Fig. 8).
The concept of mucosal micro-invasion moves us away from
current models of colonisation where the pneumococcus is held
up at the epithelial surface and that invasion leads to disease. Our
data are supported by murine colonisation experiments38,39 and
the detection of pneumococcal DNA in blood of otherwise
healthy, colonised children40. In line with other cell culture and
murine models13,16,38,41, we have demonstrated that pneumo-
coccal micro-invasion occurs by endocytosis through the for-
mation of cytoplasmic vacuoles, and by paracellular transcytosis
across the epithelium. This process appears to be association with
the formation of epithelial folds different from the membrane
rufﬂes previously reported with conventionally intracellular
pathogens such as Salmonella typhimurium42. Our study
emphasises the active nature of these processes without marked
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cellular damage or loss of barrier function. Micro-invasion of the
epithelium may overcome the inaccessibility of PAMP receptors
located either at the epithelial basolateral surface or
intracellularly43,44. We have found that at early time points,
micro-invasion in vitro is also characterised by pneumococcal co-
association with JAM-A and β catenin without evidence of barrier
dysfunction. In murine models at later time points, TLR-
dependent Claudin 7 and Claudin 10 downregulation enhanced
pneumococcal translocation across the epithelium has been
observed13. While this may occur as inﬂammation becomes more
prominent, our data suggest that micro-invasion can happen
without barrier disruption and that the epithelium plays an active
role in the regulation of these complex host–pathogen interac-
tions12. How micro-invasion relates to the risk of invasive
pneumococcal disease remains to be determined but as demon-
strated by the EHPC model, micro-invasion may occur in healthy
individuals without symptoms.
The differential impact of micro-invasion on the epithelial
transcriptomic response was striking with considerable
enrichment of multiple diverse transcription factors and sig-
nalling pathways related to innate immunity with the most
invasive pneumococcal strains. The interactome module
highlights that although enrichment of gene activation in
response to all pneumococcal strains are apparent (the core
module), a more diverse range of epithelial gene activation
occurs between strains, reﬂecting speciﬁc host–pathogen
interactions. Nasal colonisation in murine models is
proinﬂammatory45,46, but our in vitro and EHPC experiments
with serotype 6B suggests this is not always the case, whereby
pneumococcal-host cell adherence, growth, endocytosis and
paracellular migration can be established without a marked
host response. In the EHPC, clearance occurred around the
time the epithelial transcriptomic response was most promi-
nent. Weiser and colleagues argue that the colonising pneu-
mococcus induces a host inﬂammatory response that mediates
clearance, but also promotes nutrient acquisition, mucus
production and onward transmission14,18,47, which is sup-
ported by murine models48 and epidemiological studies of
viral-co-infection49. It has been suggested that pneumolysin
induces neutrophil inﬂux and degranulation, leading to
increased secretions from the nasopharynx, so promoting
transmission5,18. We therefore suggest that the epithelial innate
response resulting from pneumococcal colonisation could
promote both clearance and transmission.
The enrichment of binding sites for the transcription factor
KLF4 transcription factors seen in our in vitro data suggests a
counter-regulatory process aimed at minimising inﬂammation.
KLF4 plays a role in barrier function, suppression of NFκB-
dependent IL-8 secretion, regulation of IL-10 expression via
TLR9-MyD88 and Yes-1, in response to S. pneumoniae, which is
partially dependent on autolysin LytA32,50,51. Thus, by exploiting
micro-invasion, the pneumococcus may carefully calibrate the
host innate immune/inﬂammatory response to promote survival
through transmission.
A range of pneumococcal PAMPs including pneumolysin, may
trigger this epithelial sensing process18,52. We found pneumolysin
to be a prominent inducer of epithelial surface molecule upre-
gulation, cytokine production and transcriptomic inﬂammatory
response in vitro. Following internalisation of the pneumococcus
by neutrophils, pneumolysin has been shown to induce ROS
following bacterial autolysis, which leads to cellular activation53.
We speculate that pneumolysin released intracellularly may signal
directly in epithelial cells or through host cell pore-formation
leading to entry of other PAMPs. Mediated by autolysin, the
pneumococcus undergoes autolysis during stationery growth
phase, resulting in additional PAMPs’ release including bacterial
DNA53. In mice, pneumococcal DNA triggers inﬂammation
through a DAI/STING/TBK1/IRF3 cascade45,54, a response that
may contribute to pneumococcal clearance. In our in vitro
transcriptomic analyses, we detected enriched activation of IRF3/
IFR7 in dPly-TIGR4. We suggest that in the context of micro-
invasion, pneumococcal DNA may also act as a trigger of epi-
thelial sensing, inducing inﬂammation54.
Our ﬁndings are limited by the pneumococcal strains available
for testing in the EHPC model to enable direct comparisons
with in vitro data. Nonetheless, the use of different strains in vitro
has enabled us and others55,56 to determine the impact of dif-
ferent patterns of epithelial adherence and invasion on the
host inﬂammatory/innate immune response. Currently, the
EHPC model does not allow us to deﬁnitively assess human to
human transmission although the appropriate methods are under
development.
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Fig. 8Model of pneumococcal colonisation at the human mucosal epithelium. Pneumococcal adhesion and micro-colony formation on the epithelial surface
may lead to micro-invasion; internalisation of the bacteria and/or transmigration across the epithelial barrier (micro-invasion). The epithelial-derived
response is dependent on the subsequent pattern of interactions. Micro-invasion ampliﬁes epithelial sensing and inﬂammation/innate immunity, which we
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In conclusion, our data implicate the novel ﬁnding of micro-
invasion during pneumococcal colonisation of otherwise healthy
humans, promoting epithelial-derived innate immunity/inﬂam-
mation and ultimately clearance. The pathways critical for
onward pneumococcal transmission remain to be determined in
humans but based on murine models, we propose that this epi-
thelial response may also facilitate transmission. The balance
between innate immunity/inﬂammation-driven transmission and
clearance may be further modulated by the frequency of carriage
events, pneumococcal strain co-colonisation, viral co-infections
and other environmental pressures1,22,48. Our approach com-
bining in vitro with in vivo human systems offers a potentially
tractable way to further interrogate these processes.
Methods
Bacteria. S. pneumoniae clinical strains used were 6B (BHN 41857), 23F (P112158)
and TIGR4 (P167259), together with a pneumolysin deﬁcient TIGR4 mutant strain
(P1672, a kind gift from Prof T Mitchell, University of Birmingham). Stocks of
bacterial aliquots grown to O.D.600nm 0.3 were stored at −80 °C, defrosted,
resuspended in cell culture media and used once. Colony forming units (CFU) were
counted on horse blood agar plates (EO Labs).
EHPC model. Following written informed consent, healthy non-smoking adults
between the ages of 18 and 59 were inoculated with 80,000 CFU/nostril live 6B S.
pneumoniae (BHN418), grown to mid-log phase in vegetone broth60. Individuals
naturally colonised with S. pneumoniae or in regular contact with at-risk indivi-
duals were excluded. Blood and mucosal T cell and antibody immunity were not
systematically measured in this cohort but previous studies of volunteers from this
population have demonstrated background T cell and antibody-mediated anti-
pneumococcal immunity, but a relationship between pre-challenge immunity and
the development of carriage in the model has not been established21,23. To exclude
the inﬂuence of viral-co-infection, EHPC model volunteers who had coryzal or ﬂu-
like symptoms prior to challenge were excluded. Volunteers were screened for the
presence of 20 common respiratory viruses before inoculation. In total, 1/13
asymptomatic volunteers (volunteer 1) was positive for enterovirus. Nasal washes
and mucosal cells (curette biopsy) from the inferior turbinate were obtained by PBS
syringe and curettage using a plastic Rhino-probe™ (Arlington Scientiﬁc), in this
order of collection, respectively, before pneumococcal inoculation. Sampling was
then repeated on days 2, 6, 9, and 14–27 post pneumococcal inoculation61.
Volunteers received the TIV vaccine intramuscularly at day 3 post pneumococcal
inoculation. Bacteria collected from nasal washes were quantiﬁed by CFU counts.
At each time point, two curettage samples were obtained and processed for con-
focal immunoﬂuorescence, ﬂow cytometry, primary cell culture and/or tran-
scriptomic analysis by RNA sequencing (RNAseq). There were no adverse events.
The carriage status of each volunteer was blinded until sample analysis was
completed.
Ethical approval was given by NHS Research and Ethics Committee (REC)/
Liverpool School of Tropical Medicine (LSTM) REC, reference numbers: 15/NW/
0146 and 14/NW/1460 and Human Tissue Authority licensing number 12548.
Ex vivo cell culture. Primary epithelial cells were cultured according to Müller
et al.62 with modiﬁcation. Brieﬂy, nasal cell curette biopsy samples were collected in
RPMI containing Penicillin-Streptomycin (1%) and FBS (10%) before centrifuga-
tion at 400 × g for 5 min. Cells were resuspended in BEGM-AS (25 ml PneumaCult
BEGM (Bronchial Epithelial Growth Media, Stem Cell Technologies), 25 ml BEGM
(Cell Application), GA-1000 (1:2000, Lonza)) supplemented with 50 ng/ml DNase
I), incubated for 20 min at RT and centrifuged. The resuspended pellet containing
BEGM-S++ media (50 ml PneumaCult BEGM media, sodium bicarbonate (1:50,
Fisher Scientiﬁc) Nu-serum IV (1:20), GA-1000 (1:1000)), was plated into 12-well
cell culture plates (Corning) that had been coated with 300 µg/ml PureCol (Cell
System) for 30 min at 37 °C and washed with Hanks Buffer Saline Solution
(HBSS+/+, with calcium and magnesium, Gibco). 24 h after sampling, media was
replaced with BEGM-S++ and BEGM-AS+ (50 ml of BEGM-AS media, 2 nM
retinoic acid, GA-1000 (1:2000)) and applied as follows: 24 h—1:1; 48 h—1:3, 72 h
and following—1:6. At day 7, the cells were dislodged using 0.25% trypsin, placed
in a prepared 15 ml ﬂacon containing Soy trypsin inhibitor (Sigma Aldrich),
centrifuged (4 °C, 400 × g for 5 min) and resuspended in BEGM-AS+ and seeded
into a cell culture ﬂask (Corning). Cells were cultured for a maximum of 20 days.
At day 28 (week 4) cells were seeded on Corning 12 well inserts and cultured in
BEGM ALI media (25 ml DMEM high glucose, 25 ml BEGM-AS media, 50 µg/ml
Bovine Pituitary Extract, 66 µg/ml Nystatin (Fisher Scientiﬁc), 1.5 µg/ml BSA,
GA-1000 (1:4000)). Cells were seeded at a concentration of 1 × 105 cells/well and
cultured until conﬂuent. Apical and basolateral media was replaced with BEGM
ALI media supplemented with 500 nM retinoic acid for 48 h. Media was then
replaced with PneumaCult-ALI media on the basal side only. Cells were
maintained for 30 days with the apical cell surface rinsed weekly with 10 min of
HBSS+/+ and removing liquid thereafter.
Human respiratory tract epithelial cell lines. Human pharyngeal carcinoma
Detroit 562 epithelial cells (ATCC_CCL-138) and human bronchial carcinoma
Calu3 epithelial cells (ATCC_HTB-55) were grown in 10% FCS in alpha MEM
media (Gibco). Human alveolar epithelial carcinoma A549 epithelial cells
(ATCC_CCL-185) were grown in 10% FCS with 1% L-glutamine in Hams/F-12
media (Gibco).
Pneumococcal–epithelial cell co-culture. For association and invasion assays,
conﬂuent Detroit 562 (typically day 8 post plating), Calu3 (typically day 10 post
plating) and A549 (typically day 4 post plating) monolayers cultured on 12 well
plates (Corning), were exposed to S. pneumoniae for 3 h in 1% FCS alpha MEM
(MOI ~1 cell:10 pneumococci). The medium was removed, and cells washed three
times in HBSS+/+. Cells were incubated in 1% saponin for 10 min at 37 °C and
lysed by repetitive pipetting. Dilutions of bacteria were plated on blood agar and
colonies counted after 16 h. To quantify internalised bacteria, 100 µg/ml genta-
micin was added for 1 h to the cells, which were washed another three times, before
incubating with 1% Saponin and plating on blood agar plates. CFUs were counted
after 16 h incubation at 37 °C, 5% CO2. There were no differences in pneumococcal
pre- or post-inoculum, or growth density between the strains, in the cell super-
natant 3 h post-infection.
For transmigration assays, Detroit 562 cells were cultured on 3 µm pore, PET
Transwell Inserts (ThermoFisher) typically for 10 days to achieve conﬂuent,
polarised monolayers. Calu3 cells were plated onto Transwell inserts typically for
12 days and A549 cells typically for 6 days. Cell culture media was changed 1 h
prior to addition of bacteria to 1% FCS (250 µl apical chamber, 1 ml basal
chamber). Resistance was recorded before and after S. pneumoniae were added
using an EVOM2 (World Precision Instruments). In total, 1 mg/ml FITC-dextran
(Sigma Aldrich) was added to the apical chamber of selected inserts to assess
permeability. Approximately 12 million bacteria were added to the cells (~MOI 1
cell: 25 bacteria). During the time course, 50 µl was removed, diluted and plated,
from the basal chamber to measure bacterial load by counting CFU/well.
Permeability was recorded using a FLUOstar Omega (BMG Labtech) at 488 nm.
For endocytosis inhibition assays, Detroit 562 cells cultured on 12-well plates
were treated with 100 µM dynasore (Cambridge Biosciences) and 7.5 µg/ml
nystatin (Sigma Aldrich) to block endocytosis for 30 min prior to, and for the
duration of pneumococcal infection incubation period. DMSO was used as a
control. Cells were washed and treated with gentamicin and lysed with saponin as
described above.
Confocal microscopy. For the in vivo analysis, mucosal cells derived by curettage
from the EHPC model were placed directly into 4% PFA for 1 h. Cells were
cytospun onto microscope slides and allowed to air dry. For the in vitro analysis,
epithelial cell lines on transwell membranes were ﬁxed in either 4% PFA (Pierce,
Methanol Free) or 1:1 mix of methanol:acetone for 20 min. For both in vivo and
in vitro samples, cells were permeabilised with 0.2% Triton X-100 for 10 min and
blocked for 1 h in blocking buffer (3% goat serum and 3% BSA in PBS) before
incubation with either pneumococcal antisera Pool Q (for 6B or 23F detection, SSI
Diagnostica), or pneumococcal antisera Type 4 (for TIGR4 and dPly detection, SSI
Diagnostica) to detect pneumococci, and JAM-A, Claudin-4 or β-catenin primary
antibodies to detect cellular junctional proteins (see Supplementary Tables) for 1 h
and then secondary and/or conjugated antibodies for 45 min. DAPI solution was
added for 5 min. After washing, the stained samples were mounted using Aqua
PolyMount (VWR International) with a coverslip onto a microslide. The entire
cytospin for each sample was manually viewed by microscopy for detection of
pneumococci. Multiple ﬁelds of view (>3) were imaged for each transwell insert, for
each condition. Images were captured using either an inverted LSM 700, LSM 880
and analysed using the Zeiss LSM Image Browser, or captured using a TissueFAXS
Zeiss Confocal Microscope and analysed with TissueGnostics software. Z stacks
were recorded at 1 µm intervals at either ×40 oil or ×63 oil objectives. For the
in vivo samples, the operator (CMW) was blinded to the colonisation status of the
volunteer at the time of sampling.
Electron microscopy. Detroit 562 cells cultured on either transwells (scanning
EM) or coverslips (transmission EM) were ﬁxed with 2% paraformaldehyde and
1.5% glutaraldehyde in 0.1 M cacodylate buffer and post-ﬁxed in 1% OsO4/1.5%
K4Fe(CN)6 in 0.1 M cacodylate buffer pH 7.3. Samples were dehydrated in graded
ethanol–water series and inﬁltrated with Agar 100 resin mix. Ultra-thin sections
were cut at 70–80 nm using a diamond knife on a Reichert ultracut microtome.
Sections were collected on 300 mesh copper grids and stained with lead citrate.
Samples were viewed in a Joel 1010 transition electron microscope and images
recorded using a Gatan Orius camera. For scanning electron microscopy, cells were
ﬁxed in 2% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer pH 7.3 and incubated for 24 h at 3 °C. Samples are washed twice in 0.1 M
sodium cacodylate for 30 min. The samples were post-ﬁxed in 1% OsO4/1.5% K4Fe
(CN)6 in 0.1 M cacodylate buffer at 3 °C for 1.5 h. Samples were washed in 0.1 M
cacodylate buffer, rinsed in distilled water and dehydrated in a graded
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ethanol–water series to 100% ethanol (25% ethanol 5 min; 50% ethanol 5 min; 70%
ethanol 5 min; 90% ethanol 5 min and ﬁnally 100% ethanol (Annular and dry) 5
min, four times). Samples were critical point dried using CO2 and mounted on
aluminium stubs using sticky carbon taps. The mounted samples were coated with
a thin layer of ~10-nm thick Au using a sputter coater and viewed and images
recorded with a FEI.
For transmission electron microscopy, cells were ﬁxed in 2% paraformaldehyde
and 1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.3 and incubated
for 24 h at 3 °C. Samples are washed twice in 0.1 M sodium cacodylate for 30 min
and post-ﬁxed in 1% OsO4/1.5% K4Fe(CN)6 in 0.1 M cacodylate buffer pH 7.3 for
1 h at 3 °C. Samples are washed in distilled water for 5 min. The cells were
dehydrated in a graded ethanol–water series and inﬁltrated with Agar 100 epoxy
resin by the following steps: 25% ethanol 5 min; 50% ethanol 5 min; 70% ethanol 5
min; 90% ethanol 5 min; 100% ethanol (dry) 5 min, four times. This was followed
by incubation in propylene oxide for 5 min; 2:1 propylene oxide:resin for 1 h; 1:1
propylene oxide 1 parts resin mix × 1 h; 1:2 propylene oxide:resin for 1 h; 100%
resin for 4 h; 100% resin for 16 h. The epoxy resin was a medium hardness mix and
the Agar resin consisted of Agar 100 (12 gm), DDSA (8 gm), MNA (5 gm) and
BDMA (0.65 ml). The samples were hardened ready to section by placing the
coverslip cell-side down onto a resin-ﬁlled beam capsule and hardened at 60 °C for
48 h. The coverslip was removed, and a representative area was selected. Ultra-thin
sections were cut at 70–80 nm using a diamond knife on a Reichert ultra-cut S
microtome. Sections were collected on copper grids and stained with lead citrate.
Samples were viewed with a Joel 1010 transition electron microscope and the
images recorded using a Gatan Orius CCD camera.
Flow cytometry. For the in vivo analysis, cells from two curette samples were
incubated in cold PBS++ (PBS supplemented with 5 mM EDTA and 0.5% FCS)
were dislodged by pipetting and centrifuged at 440 g for 5 mins at 4 °C. Supernatant
was removed, and cells resuspended in 25 µl of PBS++ with Live/DeadTM Fixable
Violet Dead Cell Stain (ThermoFisher). After 15 min incubation on ice, an anti-
body cocktail to stain for epithelial surface marker expression (see Supplemen-
tary Information) was added and incubated for another 15 min. Samples were
vortexed, resuspended in 3.5 ml of PBS++ and ﬁltered over a pre-wetted 70 µm
ﬁlter. Samples were transferred to a 5 ml FACS tube, centrifuged and resuspended
in 200 µl Cell Fix (BD Biosciences) and acquired on LSRII Flow Cytometer (BD
Biosciences). Compensation was run and applied for each experimental replicate
and voltages consistent throughout. Isotype controls (Biolegend) and FL-1 controls
were also run for each antibody. Analyses of data was performed using FlowJo LLC
version 10 software. Data were performed on the gated epithelial cell population
and only samples containing 500 or more cells are reported.
For the in vitro analysis, conﬂuent monolayers of Detroit 562 cells on 6-well
plates were incubated with S. pneumoniae for 6 h in 1% FCS phenol free alpha
MEM (base media, Life Technologies). Cells were washed three times in PBS
and gently lifted from the plate using a cell scraper in 300 µl of base media
supplemented with 1 mM EDTA. Samples were transferred to 5 ml FACS
tubes and placed on ice for the duration of the protocol. Each cell sample was
incubated with an antibody cocktail for epithelial surface marker expression
(see Supplemental Information) and Live/DeadTM Fixable Zombie Blue UV Cell
Stain (Biolegend) for 30 min before rinsing in 1 ml base media and centrifuging at
300 × g for 5 min at 4 °C. Cells were ﬁxed in 600 µl of 4% PFA and acquired on an
LSR II Flow Cytometer (BD Biosciences). Compensation was run and applied for
each experimental replicate and voltages consistent throughout. Isotype controls
(BD Biosciences), FL-1 and single stains were also run for each experiment.
Samples were acquired until 300,000 events had been collected. Analyses were
performed using FlowJo LLC version 10 software.
ELISAs. Supernatant from Detroit 562 cells that had been incubated with S.
pneumoniae for 6 h, was collected for cytokine analysis. IL-6, IL-8 and ICAM-1
DuoSet® ELISA kits were purchased from R&D Systems and protocol followed
according to manufacturers’ instructions.
RNA samples and sequencing (RNASeq). Mucosal curettage samples and epi-
thelial cell cultures (incubated with or without S. pneumoniae for 3 h) were col-
lected in RNALater (ThermoFisher) and stored at −80 °C. RNA extraction was
performed using the RNEasy micro kit (Qiagen) and genomic DNA was removed
with on column DNA digestion or with the Turbo DNA-free Kit (Qiagen).
Extracted RNA quality was assessed and quantiﬁed using a BioAnalyser (Agilent
2100). For mucosal curettage samples, library preparation and RNA sequencing
(Illumina Hiseq 4000, 15 lanes in total with seven samples per lane, 100 bp and 75
bp paired-end reads) were performed at the Beijing Genome Institute (China) or
the Wellcome Sanger Institute (UK), respectively. For the Detroit 562 samples,
library preparation was performed using the Kappa Hyperprep kit (Roche Diag-
nostics) and sequencing was undertaken by the Pathogens Genomic Unit (UCL) on
the Illumina Nextseq using the Nextseq 500/550 High Output 75 cycle kit (Illu-
mina) according to manufacturers’ instructions, giving 15–20 million 41 bp paired-
end reads per sample.
All data processing and analysis were conducted in R, language and
environment for statistical computing (https://www.R-project.org). Paired-end
reads were mapped to the Ensembl human transcriptome reference sequence
(homo sapiens GRCh38). Mapping and generation of read counts per transcript
were performed using Kallisto63, based on pseudoalignment. R/Bioconductor
package Tximport was used to import the mapped counts data and summarise the
transcripts-level data into gene-level data64. DESeq2 and SARTools packages65
were used for differential gene expression analysis, using a false discovery rate
(FDR) <0.05, following normalisation with a negative binomial generalised linear
model. In addition, transcript abundance for protein coding genes was expressed as
log2-transformed transcripts per million (TPM) by normalising the read counts to
gene length and then read depth. Transcriptomes from nasal samples ranged from
16 to 66 million reads per sample and in principle component analysis, revealed a
batch effect that was corrected by the Combat function in the surrogate variable
analysis (SVA) R/Bioconductor package66.
Identiﬁcation of interacting networks and pathway-enrichment analysis was
performed using XGR R package67. Interacting genes (supported by at least one
experimental source of evidence) were identiﬁed from the Pathway Commons
database for directed interactions. These were then subjected to reactome pathway-
enrichment analysis with FDR <0.05. K-means clustering of Jaccard indices to
quantify similarity between the composition of genes mapping to each pathway was
used to identify 20 groups of pathways, from which the pathway consisting of the
largest total number of genes was selected to provide a representative annotation
for each group. Transcription factor binding site enrichment analysis was
performed using the human single site analysis function in oPOSSUM68. The
expression of gene modules in the nasal transcriptomes was represented by the
mean Log2 TPM value of the genes in each module.
Statistics. All experiments were conducted with replicates in three or more
independent experiments unless stated otherwise. Error bars represent SEM unless
stated otherwise. GraphPad Prism Version 10 was used to perform two-tailed
parametric (t-tests or ANOVA) or non-parametric (Mann–Whitney or
Kruskal–Wallis tests) analysis, which was based on the Shapiro–Wilk normality
test. P values <0.05 were considered signiﬁcant and are derived from non-
parametric statistical tests unless stated otherwise.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNAseq data from the EHPC are accessible through GEO accession code GSE124949.
RNAseq data from the Detroit 562 cell infections are accessible through the ArrayExpress
database at EMBL-EBI under accession number E-MTAB-7841. Data from differential
gene expression from upregulated genes following infection, Reactome pathways and
transcription factor analysis can be found in Supplementary Data 1–4. Source data for
ﬁgures are provided as a Source Data ﬁle.
Code availability
Codes used to process the RNAseq data can be found at https://github.com/
cristina86cristina.
Received: 12 August 2018 Accepted: 4 June 2019
References
1. O’Brien, K. L. et al. Burden of disease caused by Streptococcus pneumoniae
in children younger than 5 years: global estimates. Lancet 374, 893–902
(2009).
2. Whitney, C. G. et al. Decline in invasive pneumococcal disease after the
introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348,
1737–1746 (2003).
3. Hanage, W. P. et al. Carried pneumococci in Massachusetts children: the
contribution of clonal expansion and serotype switching. Pedia. Infect. Dis. J.
30, 302–308 (2011).
4. Jochems, S. P., Weiser, J. N., Malley, R. & Ferreira, D. M. The immunological
mechanisms that control pneumococcal carriage. PLoS Pathog. 13, e1006665
(2017).
5. Diavatopoulos, D. A. et al. Inﬂuenza A virus facilitates Streptococcus
pneumoniae transmission and disease. FASEB J. 24, 1789–1798 (2010).
6. Pido-Lopez, J., Kwok, W. W., Mitchell, T. J., Heyderman, R. S. & Williams, N.
A. Acquisition of pneumococci speciﬁc effector and regulatory Cd4+ T cells
localising within human upper respiratory-tract mucosal lymphoid tissue.
PLoS Pathog. 7, e1002396 (2011).
7. Zhang, Q. et al. Characterisation of regulatory T cells in nasal associated
lymphoid tissue in children: relationships with pneumococcal colonization.
PLoS Pathog. 7, e1002175 (2011).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11005-2 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3060 | https://doi.org/10.1038/s41467-019-11005-2 | www.nature.com/naturecommunications 13
8. Pennington, S. H. et al. Polysaccharide-speciﬁc memory B cells predict
protection against experimental human pneumococcal carriage. Am. J. Respir.
Crit. Care Med. 194, 1523–1531 (2016).
9. Mitsi, E. et al. Agglutination by anti-capsular polysaccharide antibody is
associated with protection against experimental human pneumococcal
carriage. Mucosal Immunol. 10, 385–394 (2017).
10. Ratner, A. J., Lysenko, E. S., Paul, M. N. & Weiser, J. N. Synergistic
proinﬂammatory responses induced by polymicrobial colonization
of epithelial surfaces. Proc. Natl Acad. Sci. USA 102, 3429–3434
(2005).
11. Eisele, N. A. & Anderson, D. M. Host defense and the airway epithelium:
frontline responses that protect against bacterial invasion and pneumonia. J.
Pathog. 2011, 249802 (2011).
12. Whitsett, J. A. & Alenghat, T. Respiratory epithelial cells orchestrate
pulmonary innate immunity. Nat. Immunol. 16, 27–35 (2015).
13. Clarke, T. B., Francella, N., Huegel, A. & Weiser, J. N. Invasive bacterial
pathogens exploit TLR-mediated downregulation of tight junction
components to facilitate translocation across the epithelium. Cell Host Microbe
9, 404–414 (2011).
14. Weiser, J. N., Ferreira, D. M. & Paton, J. C. Streptococcus pneumoniae:
transmission, colonization and invasion. Nat. Rev. Microbiol. 16, 355–367
(2018).
15. Agarwal, V., Asmat, T. M., Dierdorf, N. I., Hauck, C. R. & Hammerschmidt, S.
Polymeric immunoglobulin receptor-mediated invasion of Streptococcus
pneumoniae into host cells requires a coordinate signaling of SRC family of
protein-tyrosine kinases, ERK, and c-Jun N-terminal kinase. J. Biol. Chem.
285, 35615–35623 (2010).
16. Asmat, T. M., Agarwal, V., Saleh, M. & Hammerschmidt, S. Endocytosis of
Streptococcus pneumoniae via the polymeric immunoglobulin receptor of
epithelial cells relies on clathrin and caveolin dependent mechanisms. Int J.
Med. Microbiol. 304, 1233–1246 (2014).
17. Ratner, A. J., Aguilar, J. L., Shchepetov, M., Lysenko, E. S. & Weiser, J. N.
Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria.
Cell Microbiol. 9, 1343–1351 (2007).
18. Zafar, M. A., Wang, Y., Hamaguchi, S. & Weiser, J. N. Host-to-host
transmission of Streptococcus pneumoniae is driven by its inﬂammatory toxin,
pneumolysin. Cell Host Microbe 21, 73–83 (2017).
19. Malley, R. et al. Recognition of pneumolysin by Toll-like receptor 4 confers
resistance to pneumococcal infection. Proc. Natl Acad. Sci. USA 100,
1966–1971 (2003).
20. Ratner, A. J. et al. Epithelial cells are sensitive detectors of bacterial pore-
forming toxins. J. Biol. Chem. 281, 12994–12998 (2006).
21. Ferreira, D. M. et al. Controlled human infection and rechallenge with
Streptococcus pneumoniae reveals the protective efﬁcacy of carriage in healthy
adults. Am. J. Respir. Crit. Care Med. 187, 855–864 (2013).
22. Jochems, S. P. et al. Inﬂammation induced by inﬂuenza virus impairs human
innate immune control of pneumococcus. Nat. Immunol. 19, 1299–1308
(2018).
23. Wright, A. K. et al. Human nasal challenge with Streptococcus pneumoniae is
immunising in the absence of carriage. PLoS Pathog. 8, e1002622 (2012).
24. Trevejo-Nunez, G., Elsegeiny, W., Conboy, P., Chen, K. & Kolls, J. K. Critical
role of IL-22/IL22-RA1 signaling in pneumococcal pneumonia. J. Immunol.
197, 1877–1883 (2016).
25. Fais, S. et al. HLA-DR antigens on colonic epithelial cells in inﬂammatory
bowel disease: I. Relation to the state of activation of lamina propria
lymphocytes and to the epithelial expression of other surface markers. Clin.
Exp. Immunol. 68, 605–612 (1987).
26. Propst, S. M., Denson, R., Rothstein, E., Estell, K. & Schwiebert, L. M.
Proinﬂammatory and Th2-derived cytokines modulate CD40-mediated
expression of inﬂammatory mediators in airway epithelia: implications for the
role of epithelial CD40 in airway inﬂammation. J. Immunol. 165, 2214–2221
(2000).
27. Cagnoni, F. et al. CD40 on adult human airway epithelial cells: expression and
proinﬂammatory effects. J. Immunol. 172, 3205–3214 (2004).
28. Frick, A. G. et al. Haemophilus inﬂuenzae stimulates ICAM-1 expression on
respiratory epithelial cells. J. Immunol. 164, 4185–4196 (2000).
29. Tettelin, H. et al. Complete genome sequence of a virulent isolate of
Streptococcus pneumoniae. Science 293, 498–506 (2001).
30. Asmat, T. M., Agarwal, V., Rath, S., Hildebrandt, J. P. & Hammerschmidt, S.
Streptococcus pneumoniae infection of host epithelial cells via polymeric
immunoglobulin receptor transiently induces calcium release from
intracellular stores. J. Biol. Chem. 286, 17861–17869 (2011).
31. Peter, A. et al. Localization and pneumococcal alteration of junction proteins
in the human alveolar-capillary compartment. Histochem. Cell Biol. 147,
707–719 (2017).
32. Herta, T. et al. DNA-release by Streptococcus pneumoniae autolysin LytA
induced Krueppel-like factor 4 expression in macrophages. Sci. Rep. 8, 5723
(2018).
33. Malley, R. et al. Recognition of pneumolysin by Toll-like receptor 4 confers
resistance to pneumococcal infection. Proc. Natl Acad. Sci. USA 100,
1966–1971 (2003).
34. Takahashi, S. et al. Pneumococcal infection aggravates elastase-induced
emphysema via matrix metalloproteinase 12 overexpression. J. Infect. Dis. 213,
1018–1030 (2016).
35. Pollara, G. et al. Validation of immune cell modules in multicellular
transcriptomic data. PLoS ONE 12, e0169271 (2017).
36. Schmeck, B. et al. Streptococcus pneumoniae induced c-Jun-N-terminal
kinase- and AP-1-dependent IL-8 release by lung epithelial BEAS-2B cells.
Respir. Res. 7, 98 (2006).
37. Siegel, S. J. & Weiser, J. N. Mechanisms of bacterial colonization of the
respiratory tract. Annu. Rev. Microbiol. 69, 425–444 (2015).
38. Mahdi, L. K., Ogunniyi, A. D., LeMessurier, K. S. & Paton, J. C. Pneumococcal
virulence gene expression and host cytokine proﬁles during pathogenesis of
invasive disease. Infect. Immun. 76, 646–657 (2008).
39. Briles, D. E., Novak, L., Hotomi, M., van Ginkel, F. W. & King, J. Nasal
colonization with Streptococcus pneumoniae includes subpopulations
of surface and invasive pneumococci. Infect. Immun. 73, 6945–6951
(2005).
40. Morpeth, S. C. et al. Detection of pneumococcal DNA in blood by polymerase
chain reaction for diagnosing pneumococcal pneumonia in young children
from low- and middle-income countries. Clin. Infect. Dis. 64, S347–S356
(2017).
41. Talbot, U. M., Paton, A. W. & Paton, J. C. Uptake of Streptococcus
pneumoniae by respiratory epithelial cells. Infect. Immun. 64, 3772–3777
(1996).
42. Jones, B. D., Paterson, H. F., Hall, A. & Falkow, S. Salmonella typhimurium
induces membrane rufﬂing by a growth factor-receptor-independent
mechanism. Proc. Natl Acad. Sci. USA 90, 10390–10394 (1993).
43. Gewirtz, A. T., Navas, T. A., Lyons, S., Godowski, P. J. & Madara, J. L. Cutting
edge: bacterial ﬂagellin activates basolaterally expressed TLR5 to induce
epithelial proinﬂammatory gene expression. J. Immunol. 167, 1882–1885
(2001).
44. Hornef, M. W., Wick, M. J., Rhen, M. & Normark, S. Bacterial strategies for
overcoming host innate and adaptive immune responses. Nat. Immunol. 3,
1033–1040 (2002).
45. Koppe, U. et al. Streptococcus pneumoniae stimulates a STING- and IFN
regulatory factor 3-dependent type I IFN production in macrophages, which
regulates RANTES production in macrophages, cocultured alveolar epithelial
cells, and mouse lungs. J. Immunol. 188, 811–817 (2012).
46. Wilson, R. et al. Protection against Streptococcus pneumoniae lung infection
after nasopharyngeal colonization requires both humoral and cellular immune
responses. Mucosal Immunol. 8, 627–639 (2015).
47. Zafar, M. A., Kono, M., Wang, Y., Zangari, T. & Weiser, J. N. Infant mouse
model for the study of shedding and transmission during Streptococcus
pneumoniae monoinfection. Infect. Immun. 84, 2714–2722 (2016).
48. Plotkowski, M. C., Puchelle, E., Beck, G., Jacquot, J. & Hannoun, C. Adherence
of type I Streptococcus pneumoniae to tracheal epithelium of mice infected
with inﬂuenza A/PR8 virus. Am. Rev. Respir. Dis. 134, 1040–1044 (1986).
49. Pittet, L. A., Hall-Stoodley, L., Rutkowski, M. R. & Harmsen, A. G. Inﬂuenza
virus infection decreases tracheal mucociliary velocity and clearance of
Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 42, 450–460 (2010).
50. Zahlten, J. et al. Role of pneumococcal autolysin for KLF4 expression and
chemokine secretion in lung epithelium. Am. J. Respir. Cell Mol. Biol. 53,
544–554 (2015).
51. Zahlten, J. et al. TLR9- and Src-dependent expression of Krueppel-like factor 4
controls interleukin-10 expression in pneumonia. Eur. Respir. J. 41, 384–391
(2013).
52. Hotomi, M., Yuasa, J., Briles, D. E. & Yamanaka, N. Pneumolysin plays a key
role at the initial step of establishing pneumococcal nasal colonization. Folia
Microbiol. 61, 375–383 (2016).
53. Martner, A., Dahlgren, C., Paton, J. C. & Wold, A. E. Pneumolysin released
during Streptococcus pneumoniae autolysis is a potent activator of intracellular
oxygen radical production in neutrophils. Infect. Immun. 76, 4079–4087
(2008).
54. Parker, D. et al. Streptococcus pneumoniae DNA initiates type I interferon
signaling in the respiratory tract. MBio 2, e00016–00011 (2011).
55. Bootsma, H. J., Egmont-Petersen, M. & Hermans, P. W. Analysis of the
in vitro transcriptional response of human pharyngeal epithelial cells to
adherent Streptococcus pneumoniae: evidence for a distinct response to
encapsulated strains. Infect. Immun. 75, 5489–5499 (2007).
56. Novick, S. et al. Adhesion and invasion of Streptococcus pneumoniae to
primary and secondary respiratory epithelial cells. Mol. Med. Rep. 15, 65–74
(2017).
57. Browall, S. et al. Intraclonal variations among Streptococcus pneumoniae
isolates inﬂuence the likelihood of invasive disease in children. J. Infect. Dis.
209, 377–388 (2014).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11005-2
14 NATURE COMMUNICATIONS |         (2019) 10:3060 | https://doi.org/10.1038/s41467-019-11005-2 | www.nature.com/naturecommunications
58. McCool, T. L., Cate, T. R., Moy, G. & Weiser, J. N. The immune response to
pneumococcal proteins during experimental human carriage. J. Exp. Med. 195,
359–365 (2002).
59. Hyams, C., Camberlein, E., Cohen, J. M., Bax, K. & Brown, J. S. The
Streptococcus pneumoniae capsule inhibits complement activity and
neutrophil phagocytosis by multiple mechanisms. Infect. Immun. 78, 704–715
(2010).
60. Collins, A. M. et al. First human challenge testing of a pneumococcal vaccine.
Double-blind randomized controlled trial. Am. J. Respir. Crit. Care Med. 192,
853–858 (2015).
61. Jochems, S. P. et al. Novel analysis of immune cells from nasal microbiopsy
demonstrates reliable, reproducible data for immune populations, and
superior cytokine detection compared to nasal wash. PLoS ONE 12, e0169805
(2017).
62. Muller, L., Brighton, L. E., Carson, J. L., Fischer, W. A., 2nd & Jaspers, I.
Culturing of human nasal epithelial cells at the air liquid interface. J. Vis. Exp.,
https://doi.org/10.3791/50646 (2013).
63. Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic
RNA-seq quantiﬁcation. Nat. Biotechnol. 34, 525–527 (2016).
64. Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq:
transcript-level estimates improve gene-level inferences. F1000Res. 4, 1521
(2015).
65. Varet, H., Brillet-Gueguen, L., Coppee, J. Y. & Dillies, M. A. SARTools: a
DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis
of RNA-seq data. PLoS ONE 11, e0157022 (2016).
66. Chakraborty, S., Datta, S. & Datta, S. Surrogate variable analysis using partial
least squares (SVA-PLS) in gene expression studies. Bioinformatics 28,
799–806 (2012).
67. Fang, H., Knezevic, B., Burnham, K. L. & Knight, J. C. XGR software for
enhanced interpretation of genomic summary data, illustrated by application
to immunological traits. Genome Med. 8, 129 (2016).
68. Kwon, A. T., Arenillas, D. J., Worsley Hunt, R. & Wasserman, W. W.
oPOSSUM-3: advanced analysis of regulatory motif over-representation
across genes or ChIP-Seq datasets. G3 (Bethesda) 2, 987–1002 (2012).
Acknowledgements
This study was funded by the Wellcome Trust (Grant 106846/Z/15/Z). CW and RSH are
supported by the NIHR Global Health Research Unit on Mucosal Pathogens (Grant 16/
136/46) using UK aid from the UK Government. The views expressed in this publication
are those of the author(s) and not necessarily those of the NIHR or the Department of
Health and Social Care. D.M.F. is supported by the Medical Research Council (grant MR/
M011569/1), Bill and Melinda Gates Foundation (grant OPP1117728) and the National
Institute for Health Research (NIHR) Local Comprehensive Research Network. The
authors wish to thank the EHPC Clinical Team at LSTM and all the volunteers. Confocal
imaging facilities at LSTM were funded by a Wellcome Trust Multi-User Equipment
Grant (104936/Z/14/Z). Flow cytometric acquisition at LSTM was funded by a Wellcome
Trust Multi-User Equipment Grant (104936/Z/14/Z). LytA PCR was performed by Prof.
D Bogaert, University of Edinburgh, UK. For in vitro data, RNAseq library preparation
was undertaken at UCL through the UCL/UCLH Biomedical Research Centre and MRC
funded Pathogen Genomics Unit (G0900950). For the in vivo data, RNAseq library
preparation was performed and by Carl Anderson at the Wellcome Sanger Institute,
Hinxton. E.M. was performed by Dr. Mark Turmaine in the Biosciences EM facility at
UCL. M.N. is supported by the Wellcome Trust. M.N and J.S.B are supported by the
NIHR Biomedical Research Centre Funding to University College Hospitals NHS
Foundation Trust and University College London.
Author contributions
C.M.W., S.P.J., D.M.F. and R.S.H. conceived and designed the study. C.M.W., S.P., S.P.J.,
J.R., E.N. and C.S. acquired the data. C.M.W., C.V., S.P.J., M.N., J.S.B., D.M.F. and R.S.H.
analysed and interpreted the data. C.M.W. wrote the ﬁrst draft of the paper. C.M.W.,
C.V., S.P., S.P.J., J.R., E.N., C.S., M.N., J.S.B., D.M.F. and R.S.H. commented on and
approved the paper.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-11005-2.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Peer review information: Nature Communications thanks Keith Klugman and other
anonymous reviewers for their contribution to the peer review of this work. Peer reviewer
reports are available.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11005-2 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3060 | https://doi.org/10.1038/s41467-019-11005-2 | www.nature.com/naturecommunications 15
